Novel Multiple Apoptotic Mechanism of Shikonin in Human Glioma Cells

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Annals of Surgical Oncology

• Publication date

  2012-03-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1245/s10434-012-2324-4PMID 22446899
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The side story of stem-like glioma cells.

  2009cited by this paper
• Growth inhibition and induction of apoptosis in human oral squamous cell carcinoma Tca-8113 cell lines by Shikonin was partly through the inactivation of NF-kappaB pathway.

  2008cited by this paper
• Induction of apoptosis by shikonin through a ROS/JNK-mediated process in Bcr/Abl-positive chronic myelogenous leukemia (CML) cells

  2008cited by this paper
• Antioxidants from a Chinese medicinal herb – Lithospermum erythrorhizon

  2008cited by this paper
• Growth inhibition and induction of apoptosis in human oral squamous cell carcinoma Tca‐8113 cell lines by shikonin was partly through the inactivation of NF‐κB pathway

  2008cited by this paper
• Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601)

  2007cited by this paper
• Apoptosis by cisplatin requires p53 mediated p38α MAPK activation through ROS generation

  2007cited by this paper
• Shikonin-induced apoptosis involves caspase-3 activity in a human bladder cancer cell line (T24).

  2007cited by this paper
• Taming glioblastoma: targeting angiogenesis.

  2007cited by this paper
• O6‐methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells

  2006cited by this paper
• Effect of shikonin on human breast cancer cells proliferation and apoptosis in vitro.

  2006cited by this paper
• Transcription-independent pro-apoptotic functions of p53.

  2005cited by this paper
• Induction of apoptosis by shikonin through coordinative modulation of the Bcl-2 family, p27, and p53, release of cytochrome c, and sequential activation of caspases in human colorectal carcinoma cells.

  2004cited by this paper
• p53-mediated cell cycle arrest and apoptosis induced by shikonin via a caspase-9-dependent mechanism in human malignant melanoma A375-S2 cells.

  2004cited by this paper
• Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis

  2004cited by this paper
• Shikonin regulates HeLa cell death via caspase-3 activation and blockage of DNA synthesis

  2004cited by this paper
• Involvement of reactive oxygen species, but not mitochondrial permeability transition in the apoptotic induction of human SK-Hep-1 hepatoma cells by shikonin.

  2003cited by this paper
• p53 has a direct apoptogenic role at the mitochondria.

  2003cited by this paper
• Expression of p53 and prognosis in children with malignant gliomas.

  2002cited by this paper
• Control of mitochondrial membrane potential and ROS formation by reversible phosphorylation of cytochrome c oxidase

  2002cited by this paper
• Physical stability of shikonin derivatives from the roots of Lithospermum erythrorhizon cultivated in Korea.

  1999cited by this paper
• Student's t test and the Glasgow Coma Scale.

  1996cited by this paper
• Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo.

  1994cited by this paper
• Clinical trial on the effects of shikonin mixture on later stage lung cancer

  1991cited by this paper
• [Clinical trial on the effects of shikonin mixture on later stage lung cancer].

  1991cited by this paper

• Shikonin inhibits epithelial-mesenchymal transition in glioblastoma cells by upregulating p53 and promoting miR-361-5p level to suppress ZEB1 expression

  2025cites this paper
• Enhanced Osteosarcoma Immunotherapy via CaCO3 Nanoparticles: Remodeling Tumor Acidic and Immune Microenvironment for Photodynamic Therapy

  2024cites this paper
• Temozolomide Resistance in Glioblastoma by NRF2: Protecting the Evil

  2023cites this paper
• Leveraging a disulfidptosis‑related lncRNAs signature for predicting the prognosis and immunotherapy of glioma

  2023cites this paper
• Promising Nanomedicines of Shikonin for Cancer Therapy

  2023cites this paper
• Harnessing oxidative stress for anti-glioma therapy.

  2022cites this paper
• Shikonin Could Be Used to Treat Tubal Pregnancy via Enhancing Ferroptosis Sensitivity

  2022cites this paper
• Naphthoquinones and derivatives as potential anticancer agents: An updated review.

  2022cites this paper
• Induction of apoptosis by Shikonin through ROS-mediated intrinsic and extrinsic apoptotic pathways in primary effusion lymphoma

  2021cites this paper
• TEM1-targeting PEGylated PLGA shikonin nanoformulation for immunomodulation and eradication of ovarian cancer

  2021cites this paper
• An improved and practical synthesis route to antiproliferative (±)-shikonin and its O-acyl derivatives

  2020cites this paper
• Shikonin induces tumor apoptosis in glioma cells via endoplasmic reticulum stress, and Bax/Bak mediated mitochondrial outer membrane permeability.

  2020cites this paper
• The synthesis and anticancer activity of 2-styrylquinoline derivatives. A p53 independent mechanism of action.

  2019cites this paper
• Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine

  2019cites this paper
• The diverse mechanisms and anticancer potential of naphthoquinones

  2019cites this paper
• Pharmacological Properties and Derivatives of Shikonin-A Review in Recent Years.

  2019cites this paper
• Shikonin: A Review with a Focus on Anti-inflammatory and Anticancer Mechanisms

  2019cites this paper
• Natural product like “shikonin” might be a hope for Breast cancer cure

  2019cites this paper
• RIP1 and RIP3 contribute to shikonin-induced glycolysis suppression in glioma cells via increase of intracellular hydrogen peroxide.

  2018cites this paper
• Lactoferrin functionalized PEG-PLGA nanoparticles of shikonin for brain targeting therapy of glioma.

  2018cites this paper
• Radical Scavenging and Endogenous Defence System Inducing Activities of 5-[(4-Chlorophenoxy)methyl]-1,3,4-oxadiazole-2-thiol: A Novel Antioxidant

  2018cites this paper
• Antiproliferative activity of Juglone derivatives on rat glioma

  2017cites this paper
• Metabolic profiling study of shikonin's cytotoxic activity in the Huh7 human hepatoma cell line.

  2017cites this paper
• Anticancer , Antimicrobial and other Pharmacological Properties of Shikonin and its Derivatives

  2016cites this paper
• Mechanisms of Antiradical Activity of 2,3,5,6,8-Pentahydroxy-7-Ethyl-1,4-Naphthoquinone (A Review)

  2016cites this paper
• Prisconnatanones A, a cytotoxic naphthoquinone from Prismatomeris connata, suppresses the proliferation of human laryngocarcinoma HEp-2 cells in vitro

  2016cites this paper
• Biosynthesis and molecular actions of specialized 1,4-naphthoquinone natural products produced by horticultural plants

  2016cites this paper
• Shikonin induces apoptosis of HaCaT cells via the mitochondrial, Erk and Akt pathways

  2016cites this paper
• Mitochondrial Dysfunction in Gliomas: Pharmacotherapeutic Potential of Natural Compounds

  2016cites this paper
• Shikonin and its derivatives inhibit the epidermal growth factor receptor signaling and synergistically kill glioblastoma cells in combination with erlotinib

  2015cites this paper
• Inhibition of NADPH Oxidase-4 Potentiates 2-Deoxy-d-Glucose-Induced Suppression of Glycolysis, Migration, and Invasion in Glioblastoma Cells: Role of the Akt/HIF1α/HK-2 Signaling Axis

  2015cites this paper
• Shikonin selectively induces apoptosis in human prostate cancer cells through the endoplasmic reticulum stress and mitochondrial apoptotic pathway

  2015cites this paper
• Single- and Repeat-dose Oral Toxicity Studies of Lithospermum erythrorhizon Extract in Dogs

  2015cites this paper
• Shikonin induces apoptosis in the human gastric cancer cells HGC-27 through mitochondria-mediated pathway

  2015cites this paper
• Shikonin time-dependently induced necrosis or apoptosis in gastric cancer cells via generation of reactive oxygen species.

  2014influential citation
• An Oxidative Stress Mechanism of Shikonin in Human Glioma Cells

  2014cites this paper
• Shikonin-loaded antibody-armed nanoparticles for targeted therapy of ovarian cancer

  2014cites this paper
• Shikonin suppresses tumor growth and synergizes with gemcitabine in a pancreatic cancer xenograft model: Involvement of NF-κB signaling pathway.

  2014cites this paper
• Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cells

  2014cites this paper
• Chimaphilin induces apoptosis in human breast cancer MCF-7 cells through a ROS-mediated mitochondrial pathway.

  2014cites this paper
• In Vitro Induction of Erythrocyte Phosphatidylserine Translocation by the Natural Naphthoquinone Shikonin

  2014cites this paper
• Shikonin Kills Glioma Cells through Necroptosis Mediated by RIP-1

  2013influential citation
• Naftoquinonas: de simples pigmentos a moléculas terapéuticas

  2013cites this paper
• Chapter 3 – Phenolics

  2013cites this paper
• Traditional chinese medicine remedy to jury: the pharmacological basis for the use of shikonin as an anticancer therapy.

  2013cites this paper
• Topoisomerase I Inhibitors, Shikonin and Topotecan, Inhibit Growth and Induce Apoptosis of Glioma Cells and Glioma Stem Cells

  2013cites this paper
• Shikonin Protects Dopaminergic Cell Line PC12 Against 6-Hydroxydopamine-Mediated Neurotoxicity Via Both Glutathione-Dependent and Independent Pathways and by Inhibiting Apoptosis

  2013cites this paper
• The Critical Role of Redox Homeostasis in Shikonin-Induced HL-60 Cell Differentiation via Unique Modulation of the Nrf2/ARE Pathway

  2012cites this paper
• ESTUDO DA CONTRIBUIÇÃO DAS INTEGRINAS NA MOTILIDADE DE CÉLULAS DE GLIOBLASTOMA

  2012cites this paper